Medy-Tox · 연결재무제표기준영업(잠정)실적(공정공시)
Preliminary consolidated operating results (Fair Disclosure)
| Results Period | |||
| Current Period Results | 2026-07-01 | ~ | 2026-09-30 |
| Prior Period Results | 2026-04-01 | ~ | 2026-06-30 |
| Prior-Year Same Period Results | 2025-07-01 | ~ | 2025-09-30 |
| Current Period Cumulative Results | 2026-01-01 | ~ | 2026-09-30 |
| Prior-Year Same Period Cumulative Results | 2025-01-01 | ~ | 2025-09-30 |
| ※ This information is preliminary, not final, and may differ from final figures. | ||||||||
| 1. Consolidated results | ||||||||
| Category (Unit: KRW m, %) | Current Period Results | Prior Period Results | vs. Prior Period | Prior-Year Same Period Results | YoY | |||
| (2026.3Q) | (2026.2Q) | Change (%) | Profit/loss turnaround | (2025.3Q ) | Change (%) | Profit/loss turnaround | ||
| Revenue | Current Results | 59,315 | 68,702 | -13.7 | - | 61,017 | -2.8 | - |
| Cumulative Results | 188,705 | - | - | - | 186,621 | 1.1 | - | |
| Operating Income | Current Results | 15,531 | 4,765 | 225.9 | - | 8,899 | 74.5 | - |
| Cumulative Results | 27,668 | - | - | - | 20,693 | 33.7 | - | |
| Income from continuing operations before income tax | Current Results | 13,741 | 4,259 | 222.6 | - | 7,780 | 76.6 | - |
| Cumulative Results | 27,702 | - | - | - | 20,566 | 34.7 | - | |
| Net Income | Current Results | 11,616 | 3,128 | 271.4 | - | 7,199 | 61.4 | - |
| Cumulative Results | 22,623 | - | - | - | 18,716 | 20.9 | - | |
| Net income attributable to owners of the parent | Current Results | 11,572 | 3,107 | 272.4 | - | 7,434 | 55.7 | - |
| Cumulative Results | 22,475 | - | - | - | 19,612 | 14.6 | - | |
| - | - | - | - | - | - | - | - | |
| 2. Information Provided | Information Provider | (주)메디톡스 | ||||||
| Information Recipient | 국내외 정보이용자 | |||||||
| Information release date (scheduled) | 공정공시 후 투자자제공 | |||||||
| Information release time (scheduled) | - | |||||||
| Event Name (Venue) | - | |||||||
| 3. Contact | Chief Disclosure Officer (Name) | 신효진 | ||||||
| Chief Disclosure Officer (Phone) | 02-3471-8319 | |||||||
| Disclosure Officer (Name) | 김웅규 | |||||||
| Disclosure Officer (Phone) | 02-3471-8319 | |||||||
| Department Name | IR Team | |||||||
| Department (Phone) | 02-6901-5871 | |||||||
| 4. Other Matters Relevant to Investment Decisions | 1) 상기 실적자료는 한국채택국제회계기준(K-IFRS)에 따라 작성된 연결기준 영업(잠정) 실적입니다. 2) 상기 실적은 외부감사인의 회계검토가 완료되지 않은 상태에서 투자자 편의를 위해 작성된 것으로 회계검토과정에서 변경될 수 있습니다. 3) 기타 자세한 사항은 당사 홈페이지(https://www.medytox.com)를 참조하시기 바랍니다. | |||||||
| ※ Related Disclosures | - | |||||||